Sideinnhold
A -
B -
C -
D -
E -
F -
G -
H -
I -
J -
K -
L -
M -
N -
O -
P -
Q -
R -
S -
T -
U -
V -
X -
Y -
Z
|
Sancuso | granisetron | Kvalme | 2015 |
| Sandostatin LAR | oktreotid acetat | Diverse | 2016 |
| Scenesse (S) | afamelanotid | EPP | 2018 |
| Seebri | glykopyrronium | KOLS | 2013 |
| Segluromet | ertugliflozin/ metformin | Diabetes type 2 | 2018 |
| Seretide | flutikason, salmeterol | KOLS | 2009 |
| quetiapin | Schizofreni | 2012 |
| Seroquel Depot | quetiapin | Bipolar lidelse | 2013 |
| pramipexol | Restless Legs Syndrome | 2007 |
| Simbrinza | brinzolamid/ brimonidintartrat | Glaukom | 2014 |
| Sivextro | tedizolid | Alvorlige postoperative infeksjoner | 2015 |
| Skilarence (S) | dimetylfumarat | Plakkpsoriasis | 2018 |
| Skyrizi (S) | risankizumab | Plakkpsoriasis | 2019 |
| Softacort | hydrokortison | Allergisk konjunktivitt | 2018 |
Sovaldi
Sovaldi | sofosbuvir | Hepatitt C
Oppdatert rapport genotype 3 | 2015
2015 |
| Spinraza (S) | Nusinersen | Spinal muskelatrofi | 2017 |
| Spiolto | tiotropium, olodaterol | KOLS | 2015 |
| tiotropiumbromid | KOLS | 2008 |
| Spiriva | tiotropiumbromid | Astma | 2016 |
| Steglatro | ertugliflozin | Diabetes type 2 | 2018 |
| Steglujan | ertugliflozin/ sitagliptin | Diabetes type 2 | 2018 |
| Stelara (S) | ustekinumab | Crohns sykdom | 2017 |
| Stelara (S) | ustekinumab | Ulcerøs kolitt | 2019 |
|
Stivarga | regorafenib | GIST | 2016 |
| Stivarga (S) | regorafenib | Kolorektalkreft | 2018 |
| Stivarga (S) | regorafenib | Leverkreft | 2018 |
| atomoksetin | ADHD | 2008 |
| Suliqua | insulin glargin/lixisenatid | Diabetes type 2 | 2018 |
| sunitinib | GIST | 2007 |
| sunitinib | Nyrecellecarcinom | 2007 |
| sunitinib | Nyrecellecarcinom | 2010 |
| asenapin | Maniske episoder i BD | 2012 |
| budesonid, formoterol | KOLS | 2009 |
| Symtuza (S) | darunavir/kobicistat/ emtricitabin/tenofoviralafenamid | HIV | 2018 |
| Synjardy | empagliflozin | Diabetes type 2 | 2015 |
